encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 

Killer Cells, Lymphokine-Activated

More information in Books or onNLM PubMed
Definition: Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.  if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM)   
See Also Immunotherapy, Adoptive; Interleukin-2 		Other names Lymphokine-Activated Killer Cells; LAK Cells; Lymphokine-Activated Killer Cell; Lymphokine Activated Killer Cells; Killer Cells, Lymphokine Activated; Killer Cell, Lymphokine-Activated; Cells, Lymphokine-Activated Killer; Cells, LAK; Cell, Lymphokine-Activated Killer; Cell, LAK; LAK Cell

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy